Absence of Clinical Prognostic Value of Vascular Endothelial Growth Factor and Microvessel Density in Multiple Myeloma
β Scribed by Jung-Hye Choi; Myung-Ju Ahn; Se-Jin Jang; Chan-Kum Park; Yong-Wook Park; Ho-Suk Oh; Young-Yuel Lee; Il-Young Choi; In-Soon Kim
- Publisher
- Carden Jennings Publishing
- Year
- 2002
- Tongue
- English
- Weight
- 114 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Many studies have shown that angiogenesis plays an important role in the growth, progression, and metastasis of solid tumors. Recently, several angiogenic factors have been identified. Vascular endothelial growth factor (VEGF) is thought to be one such angiogenic factor and is also thought to be a s
As in other tumors, the assessment of microvessel density (MVD) in hepatocellular carcinoma (HCC) may be essential to perform an effective anti-angiogenic therapy for this tumor. The relationship between vascular endothelial growth factor (VEGF) and MVD of HCC as well as the surrounding liver remain
## Abstract ## BACKGROUND. Caveolinβ1, which has been proposed as a candidate tumor suppressor, plays a regulatory role in several signaling pathways. The importance of caveolinβ1 in endothelial cells in angiogenesis has been confirmed. The clinicopathologic significance of caveolinβ1 expression a